Victory Capital Management’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-70,837
| Closed | -$734K | – | 2542 |
|
|
2023
Q1 | $734K | Sell |
70,837
-97,231
| -58% | -$1.01M | ﹤0.01% | 1850 |
|
|
2022
Q4 | $1.98M | Buy |
168,068
+105,439
| +168% | +$1.25M | ﹤0.01% | 1442 |
|
|
2022
Q3 | $1.32M | Buy |
62,629
+27,456
| +78% | +$576K | ﹤0.01% | 1612 |
|
|
2022
Q2 | $1.09M | Buy |
35,173
+2,525
| +8% | +$78.3K | ﹤0.01% | 1699 |
|
|
2022
Q1 | $1.06M | Buy |
32,648
+11,152
| +52% | +$361K | ﹤0.01% | 1787 |
|
|
2021
Q4 | $934K | Buy |
21,496
+657
| +3% | +$28.5K | ﹤0.01% | 1873 |
|
|
2021
Q3 | $1.04M | Buy |
20,839
+658
| +3% | +$32.9K | ﹤0.01% | 1844 |
|
|
2021
Q2 | $1.27M | Sell |
20,181
-24,910
| -55% | -$1.57M | ﹤0.01% | 1807 |
|
|
2021
Q1 | $4.19M | Buy |
45,091
+30,787
| +215% | +$2.86M | ﹤0.01% | 1403 |
|
|
2020
Q4 | $1.28M | Sell |
14,304
-23,302
| -62% | -$2.09M | ﹤0.01% | 1675 |
|
|
2020
Q3 | $3.89M | Sell |
37,606
-2,891
| -7% | -$299K | 0.01% | 1251 |
|
|
2020
Q2 | $3.2M | Buy |
40,497
+26,265
| +185% | +$2.08M | ﹤0.01% | 1286 |
|
|
2020
Q1 | $824K | Buy |
14,232
+1,635
| +13% | +$94.7K | ﹤0.01% | 1920 |
|
|
2019
Q4 | $680K | Sell |
12,597
-181
| -1% | -$9.77K | ﹤0.01% | 1877 |
|
|
2019
Q3 | $668K | Buy |
+12,778
| New | +$668K | ﹤0.01% | 1798 |
|
|
2018
Q3 | – | Sell |
-5,809
| Closed | -$293K | – | 1816 |
|
|
2018
Q2 | $293K | Buy |
5,809
+798
| +16% | +$40.3K | ﹤0.01% | 1539 |
|
|
2018
Q1 | $264K | Sell |
5,011
-151
| -3% | -$7.96K | ﹤0.01% | 1517 |
|
|
2017
Q4 | $240K | Buy |
5,162
+447
| +9% | +$20.8K | ﹤0.01% | 1491 |
|
|
2017
Q3 | $191K | Buy |
+4,715
| New | +$191K | ﹤0.01% | 1547 |
|